Your search for "europe" matched 162 page(s).
Showing results 11 to 20.
 Celebrating its past, European Medicines Agency looks to the future of public communication
					 - Volume 34, Issue
				Celebrating its past, European Medicines Agency looks to the future of public communication
					 - Volume 34, Issue 
			
		As the European Medicines Agency (EMA) marks its 30th anniversary with a series of events at its offices in Amsterdam, one area in the spotlight is EMA’s communication with the public. The Agency has made significant strides in this area over the…
 Recent and upcoming regulatory changes in the European Region: Opportunitiess for medical writers
					 - Volume 29, Issue
				Recent and upcoming regulatory changes in the European Region: Opportunitiess for medical writers
					 - Volume 29, Issue 
			
		The European regulatory landscape for clinical trials and medical devices is in the midst of major transformation. Older policies are giving way to new regulations that emphasise more harmonised and streamlined processes for document submittal,…
 Overview of the European General Data Protection Regulation (GDPR) impact on medical writing  for clinical trials
					 - Volume 32, Issue
				Overview of the European General Data Protection Regulation (GDPR) impact on medical writing  for clinical trials
					 - Volume 32, Issue 
			
		The European General Data Protection Regulation 2016/ 679 (GDPR) aims to ensure the security and privacy of individuals in the European Union (EU). Companies located within and outside of the EU must comply with GDPR when processing personal data…
 A shot at demystifying the risk management plan for medical writers
					 - Volume 24, Issue
				A shot at demystifying the risk management plan for medical writers
					 - Volume 24, Issue 
			
		A risk management plan (RMP) is a complex regulatory document which is now required in the European Union as part of a medicine's approval process. This article offers practical guidance for medical writers who are interested in writing an RMP. In a…
 Report on the EMA Workshop on clinical trial data and transparency
					 - Volume 22, Issue
				Report on the EMA Workshop on clinical trial data and transparency
					 - Volume 22, Issue 
			
		Access to patient data gathered in clinical trials is a highly controversial and complex issue that needs to balance three aspects: the public right to transparency regarding data used to approve new medicines, protection of the data privacy rights…
 The new value of clinical data in Europe
					 - Volume 29, Issue
				The new value of clinical data in Europe
					 - Volume 29, Issue 
			
		The EU’s new Medical Devices Regulation and In-vitro Diagnostic Device Regulation has integrated and reinforced the regulatory requirements for pre- and post-market clinical trials and positioned them as vital to ensuring the safety and performance…
 On the western edge of Europe – medical writing in Portugal
					 - Volume 22, Issue
				On the western edge of Europe – medical writing in Portugal
					 - Volume 22, Issue 
			
		Within Portugal, medical writing is a new and rare profession. We describe our personal career routes to medical writing and discuss the barriers and the emerging opportunities for medical writers in Portugal. The profession of medical writing is…
 Foreword from the European Commission
					 - Volume 31, Issue
				Foreword from the European Commission
					 - Volume 31, Issue 
			
		Already 1 year has passed since the date of application of the new Medical Devices Regulation (EU) 2017/745 (MDR), replacing the previous Directives 90/385/EEC and 93/42/EEC from 26 May 2021, while for the new In Vitro Diagnostic Medical Devices…
 Allergen immunotherapy in the European regulatory environment
					 - Volume 27, Issue
				Allergen immunotherapy in the European regulatory environment
					 - Volume 27, Issue 
			
		Allergen immunotherapy (AIT) modulates the immune system to prevent and relieve allergic symptoms. Unlike allergen avoidance and medication to control symptoms, AIT targets the underlying pathophysiology of allergic diseases. AIT is now considered a…
 European Science Editing: May 2015 picks
					 - Volume 24, Issue
				European Science Editing: May 2015 picks
					 - Volume 24, Issue 
			
		In the ironically titled ‘The increasing pseudodignification of medical prose’, retired consultant Neville W. Goodman bemoans the failure of medical writers (by which he means people who write scientific papers) to use simple words.1 Goodman…
Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.
Medical Writing is listed in the following indexes:
Editor-in-Chief
Co-Editors
Senior Editor
Victoria White
Managing Editor
Alicia Brooks Waltman
Associate Editors
Section Editors
AI/Automation
Biotechnology
Digital Communication
EMWA News
Freelancing
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
Pablo Izquierdo / Alison McIntosh
In the Bookstores
Publications
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Louisa Ludwig-Begall / Sarah Kabani
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Layout Designer
Chris Monk